These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

735 related items for PubMed ID: 8796806

  • 1. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M, Darwish NA, Abdel-Aziz O.
    J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
    [Abstract] [Full Text] [Related]

  • 2. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M, el-Shobokshy AS, el-Noury AI.
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [Abstract] [Full Text] [Related]

  • 3. Angiogenin and gestational trophoblastic tumors, a promising prognostic marker.
    Shaarawy M, El-Mallah SY, Sheiba M.
    Clin Chem Lab Med; 2003 Mar; 41(3):306-10. PubMed ID: 12705339
    [Abstract] [Full Text] [Related]

  • 4. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 5. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA, Khanlian SA, Muller CY, Giddings A, Kohorn E, Berkowitz R.
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [Abstract] [Full Text] [Related]

  • 6. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W, Chyczewska E, Kovalchuk O, Tałałaj J, Izycki T, Panek B.
    Rocz Akad Med Bialymst; 2004 Aug; 49():246-51. PubMed ID: 15631351
    [Abstract] [Full Text] [Related]

  • 7. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA, Butler S.
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [Abstract] [Full Text] [Related]

  • 8. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI, Kacinski BM, Stanley ER.
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [Abstract] [Full Text] [Related]

  • 9. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A, Schiffman MH, Tsukui T, Swanson CA, Lucci J, Scott DR, Glass AG, Rush BB, Lorincz AT, Corrigan A, Burk RD, Helgesen K, Houghten RA, Sherman ME, Kurman RJ, Berzofsky JA, Kramer TR.
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [Abstract] [Full Text] [Related]

  • 10. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA, Khanlian SA, Giddings A, Butler SA, Muller CY, Hammond C, Kohorn E.
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [Abstract] [Full Text] [Related]

  • 11. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY, Yen GL.
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [Abstract] [Full Text] [Related]

  • 12. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
    Bodey B, Psenko V, Lipsey AL, Kaiser HE.
    Anticancer Res; 1996 Dec; 16(1):219-24. PubMed ID: 8615612
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [Abstract] [Full Text] [Related]

  • 15. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D.
    Roum Arch Microbiol Immunol; 2001 Apr; 60(3):183-201. PubMed ID: 12165973
    [Abstract] [Full Text] [Related]

  • 16. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.
    Wasik MA, Sioutos N, Tuttle M, Butmarc JR, Kaplan WD, Kadin ME.
    Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932
    [Abstract] [Full Text] [Related]

  • 17. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN, Csaba IF, Bohn H, Szabó DG, Szalmásy M, Menczer G.
    Oncodev Biol Med; 1982 May; 3(4):315-23. PubMed ID: 6291007
    [Abstract] [Full Text] [Related]

  • 18. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI.
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [Abstract] [Full Text] [Related]

  • 19. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
    Grinevich IuA, Tatarinov IuS, Iugrinova LG, Olefirenko GA, Dotsenko IuS.
    Vopr Onkol; 1981 Jul; 27(12):19-23. PubMed ID: 6275607
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-18 gene promoter polymorphisms in women with gestational trophoblastic diseases.
    Kashef MA, Dehaghani AS, Naeimi S, Fattahi MJ, Ghaderi A.
    J Reprod Med; 2008 Nov; 53(11):853-9. PubMed ID: 19097518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.